Litigation Details for Natera, Inc. v. NeoGenomics Laboratories, Inc. (Fed. Cir. 2024)

Natera, Inc. v. NeoGenomics Laboratories, Inc. (Fed. Cir. 2024)

Docket		Date Filed	2024-01-04
Court	Court of Appeals for the Federal Circuit	Date Terminated
Cause		Assigned To
Jury Demand		Referred To
Patents	6,807,491; 7,981,609; 8,389,578; 9,000,002
Link to Docket	External link to docket

Details for Natera, Inc. v. NeoGenomics Laboratories, Inc. (Fed. Cir. 2024)

Date Filed	Document No.	Description	Snippet	Link To Document
2024-02-09	20		continuation-in-part of application No. 13/110,685, 6,807,491 B2 10/2004 Pavlovic et al. filed… method patents. Patent No. 11,519,035 issued on December 6, 2022, Doc. 1-2 at 2, and Patent No. 11,530,454…the ’454 patent in Natera, Inc. v. Inivata, Inc., 1:22-cv-01609 (D. Del.). The same patent is also currently… assessing Natera’s patent, both on invalidity and infringement. Natera’s patent, with an alleged 2011…Despite that narrow patent description, the much-later-drafted claims of the ’035 patent generically recite	External link to document
2024-03-18	42		continuation-in-part of application No. 13/110,685, 6,807,491 B2 10/2004 Pavlovic et al. filed…10,081,839 B2 9/2018 Rabinowitz et al. 6,807,491 B2 10/2004 Pavlovic et al. … method patents. Patent No. 11,519,035 issued on December 6, 2022, Doc. 1-2 at 2, and Patent No. 11,530,454…Natera’s U.S. Patent Nos. 11,530,454 (the “’454 Patent”) and 11,519,035 (the “’035 Patent”) (collectively…7. Among these patented inventions include the ’454 Patent and the ’035 Patent, each of which Defendant	External link to document